Literature DB >> 17388751

Comparison of the Diskus inhaler and the Handihaler regarding preference and ease of use.

Job Van Der Palen1, Michiel M Eijsvogel, Bart F Kuipers, Maria Schipper, Niek A Vermue.   

Abstract

Many chronic obstructive pulmonary disease (COPD) patients use their inhaler ineffectively and there is a trend towards increased inhaler resistance. We wanted to answer two questions: Is there a difference in preference and ease of use between Diskus (DK) and Handihaler (HH)? How acceptable are inhalation resistances? Sixty COPD patients, naive to DK and HH, but experienced in the use of other inhalers, had to read the instruction leaflet and demonstrate their inhalation technique. If errors were made, instruction was given and inhalation technique was checked again. Patients had to state a preference for DK or HH. Subsequently they inhaled through a range of resistances and scored the acceptability. There was no difference in the number of instructions needed for both inhalers. One third inhaled perfectly after reading the instruction leaflet, which increased to 85% after one instruction. More patients preferred the DK (43) than the HH (16). With decreasing resistance acceptability increases, but it reaches a plateau. Patients have a clear preference for the DK. There is no difference in the number of instructions needed to obtain a perfect inhalation technique, but for some patients one instruction is not enough. The trend to increase the resistance of inhalers has reached a critical point with regard to acceptability.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17388751     DOI: 10.1089/jam.2006.0565

Source DB:  PubMed          Journal:  J Aerosol Med        ISSN: 0894-2684


  16 in total

1.  Comparing usability of NEXThaler(®) with other inhaled corticosteroid/long-acting β2-agonist fixed combination dry powder inhalers in asthma patients.

Authors:  Thomas Voshaar; Monica Spinola; Patrick Linnane; Alice Campanini; Daniel Lock; Anthony Lafratta; Mario Scuri; Barbara Ronca; Andrea S Melani
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2013-12-03       Impact factor: 2.849

2.  Delivery characteristics and patients' handling of two single-dose dry-powder inhalers used in COPD.

Authors:  Kenneth R Chapman; Charles M Fogarty; Clare Peckitt; Cheryl Lassen; Dalal Jadayel; Juergen Dederichs; Mukul Dalvi; Benjamin Kramer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-06-23

3.  Delivery characteristics of a low-resistance dry-powder inhaler used to deliver the long-acting muscarinic antagonist glycopyrronium.

Authors:  Paul Colthorpe; Thomas Voshaar; Thomas Kieckbusch; Erika Cuoghi; Juergen Jauernig
Journal:  J Drug Assess       Date:  2013-02-01

4.  A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices.

Authors:  Job van der Palen; Mike Thomas; Henry Chrystyn; Raj K Sharma; Paul Dlpm van der Valk; Martijn Goosens; Tom Wilkinson; Carol Stonham; Anoop J Chauhan; Varsha Imber; Chang-Qing Zhu; Henrik Svedsater; Neil C Barnes
Journal:  NPJ Prim Care Respir Med       Date:  2016-11-24       Impact factor: 2.871

5.  Bronchodilator efficacy of 18 μg once-daily tiotropium inhalation via Discair® versus HandiHaler® in adults with chronic obstructive pulmonary disease: randomized, active-controlled, parallel-group, open-label, Phase IV trial.

Authors:  Pinar Yildiz; Mesut Bayraktaroglu; Didem Gorgun; Funda Secik
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-11-22

Review 6.  Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes.

Authors:  Omar Sharif Usmani; Federico Lavorini; Jonathan Marshall; William Christopher Nigel Dunlop; Louise Heron; Emily Farrington; Richard Dekhuijzen
Journal:  Respir Res       Date:  2018-01-16

Review 7.  Device errors in asthma and COPD: systematic literature review and meta-analysis.

Authors:  Henry Chrystyn; Job van der Palen; Raj Sharma; Neil Barnes; Bruno Delafont; Anadi Mahajan; Mike Thomas
Journal:  NPJ Prim Care Respir Med       Date:  2017-04-03       Impact factor: 2.871

8.  Patient preferences for dry powder inhaler attributes in asthma and chronic obstructive pulmonary disease in France: a discrete choice experiment.

Authors:  Natalia Hawken; Saku Torvinen; Mohamed-Elmoctar Neine; Ikbel Amri; Mondher Toumi; Samuel Aballéa; Adam Plich; Nicolas Roche
Journal:  BMC Pulm Med       Date:  2017-07-06       Impact factor: 3.317

Review 9.  Medication adherence issues in patients treated for COPD.

Authors:  Ruben D Restrepo; Melissa T Alvarez; Leonard D Wittnebel; Helen Sorenson; Richard Wettstein; David L Vines; Jennifer Sikkema-Ortiz; Donna D Gardner; Robert L Wilkins
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

Review 10.  Optimizing identification and management of COPD patients - reviewing the role of the community pharmacist.

Authors:  Thys van der Molen; Job F M van Boven; Terence Maguire; Pankaj Goyal; Pablo Altman
Journal:  Br J Clin Pharmacol       Date:  2016-11-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.